Millennium Pharmacon (Indonesia) Management Evaluation

SDPC Stock  IDR 144.00  1.00  0.69%   
Millennium Pharmacon employs about 1.1 K people. The company is managed by 18 executives with a total tenure of roughly 107 years, averaging almost 5.0 years of service per executive, having 60.5 employees per reported executive. Inspection of Millennium Pharmacon's management performance can provide insight into the company performance.
Mohamad Mukhtar  President
President Director
Izzat Othman  President
President Commissioner, Independent Commissioner
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Millennium Pharmacon Management Team Effectiveness

The company has return on total asset (ROA) of 0.0342 % which means that it generated a profit of $0.0342 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0938 %, meaning that it generated $0.0938 on every $100 dollars invested by stockholders. Millennium Pharmacon's management efficiency ratios could be used to measure how well Millennium Pharmacon manages its routine affairs as well as how well it operates its assets and liabilities.

Millennium Pharmacon Workforce Comparison

Millennium Pharmacon International is currently regarded as top stock in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 475,385. Millennium Pharmacon adds roughly 1,089 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02.

Millennium Pharmacon Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Millennium Pharmacon Price Series Summation is a cross summation of Millennium Pharmacon price series and its benchmark/peer.

Millennium Pharmacon Notable Stakeholders

A Millennium Pharmacon stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Millennium Pharmacon often face trade-offs trying to please all of them. Millennium Pharmacon's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Millennium Pharmacon's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mohamad MukhtarPresident DirectorProfile
Izzat OthmanPresident Commissioner, Independent CommissionerProfile
Glenn AriffUnaffiliated DirectorProfile
Ahmad BakarPres DirectorProfile
Ivan HanafiIndependent DirectorProfile
Mohamad HassanF DirectorProfile
ArisChairman AuditProfile
Dian AnggreniLegal and Corporate SecretaryProfile
Ernie HilalCorporate SecretaryProfile
Yungkis SucandraHead UnitProfile
MorselaMa MarketingProfile
Puji HartonoHead UnitProfile
Nyoman RaiIndependent CommissionerProfile
Dedi MartadiredjaSr SalesProfile
Olga BolangCo SecProfile
Noraini AliCommissionerProfile
Yuni ArrivaniDeputy LegalProfile
Mohamed RahmanCommissionerProfile

About Millennium Pharmacon Management Performance

The success or failure of an entity such as Millennium Pharmacon often depends on how effective the management is. Millennium Pharmacon management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Millennium management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Millennium management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.
The data published in Millennium Pharmacon's official financial statements usually reflect Millennium Pharmacon's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Millennium Pharmacon. For example, before you start analyzing numbers published by Millennium accountants, it's critical to develop an understanding of what Millennium Pharmacon's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Millennium Pharmacon's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Millennium Pharmacon's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Millennium Pharmacon's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Millennium Pharmacon International. Please utilize our Beneish M Score to check the likelihood of Millennium Pharmacon's management manipulating its earnings.

Millennium Pharmacon Workforce Analysis

Traditionally, organizations such as Millennium Pharmacon use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Millennium Pharmacon within its industry.

Millennium Pharmacon Manpower Efficiency

Return on Millennium Pharmacon Manpower

Revenue Per Employee2.7B
Revenue Per Executive166B
Net Income Per Employee8.8M
Net Income Per Executive531.7M
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Millennium Stock analysis

When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Please note, there is a significant difference between Millennium Pharmacon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Millennium Pharmacon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Millennium Pharmacon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.